sr 47063 has been researched along with diazoxide in 1 studies
*Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. [MeSH]
*Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. [MeSH]
Studies (sr 47063) | Trials (sr 47063) | Recent Studies (post-2010) (sr 47063) | Studies (diazoxide) | Trials (diazoxide) | Recent Studies (post-2010) (diazoxide) |
---|---|---|---|---|---|
6 | 0 | 0 | 2,923 | 86 | 445 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catty, P; D'hahan, N; Jacquet, H; Moreau, C; Vivaudou, M | 1 |
1 other study(ies) available for sr 47063 and diazoxide
Article | Year |
---|---|
A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.
Topics: Animals; ATP-Binding Cassette Transporters; Chromans; Cricetinae; Diazoxide; Magnesium; Membrane Proteins; Mice; Oocytes; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Engineering; Protein Isoforms; Rats; Receptors, Drug; Recombinant Fusion Proteins; Sulfonylurea Receptors; Xenopus laevis | 1999 |